The study demonstrated a significant reduction in the level of LCMT-1 and a significant increase in the level of PME-1 in PD patients and dementia with Lewy bodies (DLB) patients compared to healthy controls, thereby showing decreased activity of PP2A in diseased brains [179]. The gene discussed is PTPA; the disease is Parkinson disease.